Table 4 Correlation of cerebrospinal fluid (CSF) and plasma soluble triggering receptor expressed on myeloid cells 2 (sTREM2) with Alzheimer’s disease (AD) biomarkers in the amyloid-negative group (N=54).
From: The relationship of soluble TREM2 to other biomarkers of sporadic Alzheimer’s disease
CSF sTREM2 | Plasma sTREM2 | ||||
|---|---|---|---|---|---|
R | P-value | R | P-value | ||
CSF | Aβ42 | 0.204 | 0.159 | –0.041 | 0.779 |
P-tau S199 | 0.301 | 0.038 | –0.142 | 0.335 | |
T-tau | 0.425 | 0.003 | –0.126 | 0.394 | |
Aβ42/P-tau S199 | – 0.178 | 0.225 | 0.115 | 0.438 | |
NfL | 0.183 | 0.208 | 0.196 | 0.177 | |
Plasma | NfL | –0.083 | 0.572 | 0.436 | 0.002 |
NRGN | –0.109 | 0.465 | – 0.246 | 0.095 | |
Telomere | –0.175 | 0.230 | – 0.312 | 0.029 | |
Age | –0.140 | 0.338 | 0.430 | 0.002 | |
